Seminar TRR 374: Therapeutic Antisense Oligonucleotides: A Maturing Technology Expanding the Universe of Targetable Drug Targets
Date: 2025-01-20Time: 1:00 PM – 2:00 PMLocation: Dr. Frank Jaschinski, CSO Secarna Pharmaceuticals | Hybrid
Seminar TRR 374: Therapeutic Antisense Oligonucleotides: A Maturing Technology Expanding the Universe of Targetable Drug Targets
Dr. Frank Jaschinski, CSO Secarna Pharmaceuticals GmbH & Co. KG, Martinsried
Time: Monday, January 20, 2025; 13:00h
Location: Seminarraum Physiologie VKL 4.1.29 Universität Regensburg and Zoom
To get the Zoom link please contact: michaela.kritzenberger@ur.de
Event Details
Dr. Frank Jaschinski, CSO Secarna Pharmaceuticals | Hybrid